Recognition of Non-Operating Income and Expenses
Filing company: Cuorips Inc.
Ministry of Economy, Trade and Industry subsidy for the Regenerative, Cellular and Gene Therapy Manufacturing Equipment Support Program (Regenerative CDMO Subsidy); issuance of new shares through a private placement conducted in September 2026
Receipt of part of the subsidy was confirmed, and registration and license tax, legal fees and other costs were incurred in connection with the issuance of new shares.
Recorded ¥169,874 thousand in subsidy income as non-operating income and ¥15,695 thousand in share issuance costs as non-operating expenses.
Cumulative second quarter of the consolidated fiscal year ending March 2027 (1 April 2026 to 30 September 2026)
The above non-operating income and non-operating expenses are reflected in the "Summary of Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending March 2027 [Japanese GAAP] (Consolidated)" released today.
Related procedures
Ministry of Economy, Trade and Industry
The above non-operating income and non-operating expenses are reflected in the "Summary of Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending March 2027 [Japanese GAAP] (Consolidated)" released today.
| Item | Details |
|---|---|
| Event name | Recognition of Non-Operating Income and Expenses |
| Date of occurrence | 30 September 2026 (receipt of part of the subsidy confirmed) / September 2026 (costs incurred in connection with the issuance of new shares through a private placement) |
| Subject Entity | Filing company: Cuorips Inc. |
| Target Locations / Products | Ministry of Economy, Trade and Industry subsidy for the Regenerative, Cellular and Gene Therapy Manufacturing Equipment Support Program (Regenerative CDMO Subsidy); issuance of new shares through a private placement conducted in September 2026 |
| Cause | Receipt of part of the subsidy was confirmed, and registration and license tax, legal fees and other costs were incurred in connection with the issuance of new shares. |
| Amount of Impact on Business Performance | Recorded ¥169,874 thousand in subsidy income as non-operating income and ¥15,695 thousand in share issuance costs as non-operating expenses. |
| Accounting period in which recognized | Cumulative second quarter of the consolidated fiscal year ending March 2027 (1 April 2026 to 30 September 2026) |
| Impact on Earnings Forecast | The above non-operating income and non-operating expenses are reflected in the "Summary of Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending March 2027 [Japanese GAAP] (Consolidated)" released today. |
| Court or authority | Ministry of Economy, Trade and Industry |
| Outlook | The above non-operating income and non-operating expenses are reflected in the "Summary of Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending March 2027 [Japanese GAAP] (Consolidated)" released today. |
Items this document does not state (15)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Because receipt of part of the Ministry of Economy, Trade and Industry's regenerative CDMO subsidy was confirmed on 30 September. In addition, registration and license tax, legal fees and other costs were incurred in connection with the issuance of new shares through a private placement conducted in September 2026.